Biosensia
Biosensia is an in vitro diagnostics company that has developed a novel point of care platform, RapiPlex. Biosensia’s proprietary RapiPlex platform integrates three technologies: A multi-channel...
View ArticleFDA Clears Single Blood Drop Test for Earlier Pregnancy Detection
NOWDiagnostics‘ ADEXUSDx product line features a lab at your fingertip, using only a single drop of blood to test for a variety of common conditions, illnesses and diseases with results in a matter of...
View ArticleLab-on-a-Chip Technology Cuts Costs of Lab Tests for HIV, Lyme Disease, Other...
The Rutgers lab-on-a chip is three inches long and an inch wide – the size of a glass microscope slide (Image Credit: Courtesy Mehdi Ghodbane) Rutgers engineers have developed a breakthrough device...
View Article10 Tips that Connect Fluid Handling with IVD Technology
All image credit: Colder Product Company The in vitro diagnostics (IVD) market continues to grow at an almost breakneck pace, along with laboratory demands for increasingly complex and efficient...
View ArticleMiroculus Acquires Kapplex to Advance Diagnostics for Complex Diseases
Miroculus, a San Francisco-based biotechnology company specializing in microRNA-based diagnostics, today announced an agreement to acquire Toronto-based Kapplex Inc. The Canadian company’s proprietary...
View ArticleRaman Scattering Method can Detect Pluripotent Stem Cells with High Sensitivity
Researchers at Emory University (Atlanta, GA) have developed an extremely sensitive technique for detecting pluripotent stem cells, which—despite their potential applications—can become tumors when...
View ArticleRainbow Seed Fund Invests in AgPlus Diagnostics
Rainbow Seed Fund, an early-stage venture capital fund focused on promising technologies developed at the UK’s largest publicly funded research facilities and campuses, today announces its investment...
View ArticleBiotech Firm Raises $17 Million in Financing Round
Adarza BioSystems Inc., a Henrietta-based company, has raised $17 million in its Series C financing round, officials said Friday. 3×5 RiverVest Fund II L.P. is the lead investor for the round. It is...
View ArticleBiosurfit 500 spinit® Instruments
Biosurfit SA (“biosurfit”), the in vitro point-of-care (PoC) diagnostics company, is pleased to announce that it has reached a significant commercial milestone, and also provides an update on recent...
View ArticleNew Atellica™ Solution, Advanced Diagnostics Analyzers from Siemens Healthineers
Siemens Healthineers announced today the CE Mark and global commercial availability of its Atellica™ Solution—flexible, scalable, automation-ready immunoassay and chemistry analyzers. The solution is...
View ArticleNew Microfluidic Chip Boosts the Sensitivity of Immunoassays
Proteins are one of the most important classes of biomarkers – biological molecules indicative of a disease or health of an individual. The detection of proteins is critical in a variety of tests; from...
View Article
More Pages to Explore .....